Results

Total Results: 52 records

Showing results for "sickle cell disease".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment_research-protocol.pdf
    September 13, 2012 - less common types of venous ulcers: genetically determined ulcers (e.g., congenital venous disease, sicklecell disease, and inherited thrombophilias); ulcers resulting from trauma in patients without signs … less common types of venous ulcers: genetically determined ulcers (e.g., congenital venous disease, sicklecell disease, and inherited thrombophilias); ulcers resulting from trauma in patients without signs
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-2.pdf
    April 01, 2022 - of pain (e.g., neuropathic, musculoskeletal [including low back pain], visceral pain, fibromyalgia, sicklecell disease, inflammatory pain, headache disorders, and degree of nociplasticity); (2) patient demographics … pain (e.g., neuropathic, musculoskeletal [including low back pain], visceral pain, fibromyalgia, sicklecell disease, inflammatory pain, headache disorders, and degree of nociplasticity); (2) patient demographics … Adjuvant interventions with opioids for vaso- occlusive crisis in sickle cell disease: A mixed treatment
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonopioid-pharm-chronic-pain-protocol.pdf
    February 01, 2019 - Neuropathic • Musculoskeletal (low back pain, neck pain and osteoarthritis) • Fibromyalgia • Sicklecell disease • Inflammatory arthritis (e.g., rheumatoid arthritis) • Chronic headachea • Pain
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia-2011_research-protocol.pdf
    January 01, 2011 - energy malnutrition secondary to an inflammatory state, hemoglobinopathies [e.g., thalassemia and sicklecell anemia])  Route of iron administration (i.e., oral or intravenous)  Treatment regimen (i.e
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioids-chronic-pain-surveillance-report-1-final.pdf
    April 01, 2022 - of pain (e.g., neuropathic, musculoskeletal [including low back pain], visceral pain, fibromyalgia, sicklecell disease, inflammatory pain, headache disorders, and degree of nociplasticity); (2) patient demographics … pain (e.g., neuropathic, musculoskeletal [including low back pain], visceral pain, fibromyalgia, sicklecell disease, inflammatory pain, headache disorders, and degree of nociplasticity); (2) patient demographics … Adjuvant interventions with opioids for vaso- occlusive crisis in sickle cell disease: A mixed treatment
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-opioid-stewardship-protocol.pdf
    July 01, 2023 - all clinical populations, we will include populations not included in the CDC guidelines, such as sicklecell disease, cancer-related pain treatment, palliative care, and end-of-life care.
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-pain-opioid-treatment_research-protocol.pdf
    December 19, 2013 - type or cause of pain (e.g., neuropathic, musculoskeletal [including low back pain], fibromyalgia, sicklecell disease, inflammatory pain, and headache disorders); 2) patient demographics (e.g., age, race … specific type or cause of pain (e.g., neuropathic, musculoskeletal [including back pain], fibromyalgia, sicklecell disease, inflammatory pain, headache disorders); 2) patient demographics; 3) patient Source:
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin-future_research.pdf
    August 01, 2014 - patient with chronic illness presenting with suspected bacterial pneumonia (e.g., in cystic fibrosis, sicklecell disease) 2. … Procalcitonin is more useful than C-reactive protein in differentiation of fever in patients with sicklecell disease. … cell disease) 3 7 7.1.
  9. effectivehealthcare.ahrq.gov/health-topics/bone-marrow-transplantation
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-3.pdf
    June 01, 2022 - of pain (e.g., neuropathic, musculoskeletal [including low back pain], visceral pain, fibromyalgia, sicklecell disease, inflammatory pain, headache disorders, and degree of nociplasticity); (2) patient demographics … pain (e.g., neuropathic, musculoskeletal [including low back pain], visceral pain, fibromyalgia, sicklecell disease, inflammatory pain, headache disorders, and degree of nociplasticity); (2) patient demographics … Adjuvant interventions with opioids for vaso- occlusive crisis in sickle cell disease: A mixed treatment
  11. effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-revised-comments.pdf
    December 29, 2020 - management, but also include ER or pre- discharge analgesia, and creates a separate exception for sicklecell disease.
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_executive.pdf
    September 19, 2014 - type or cause of pain (e.g., neuropathic, musculoskeletal [including low back pain], fibromyalgia, sicklecell disease, inflammatory pain, and headache disorders); (2) patient demographics (e.g., age, race … cell disease, inflammatory pain, headache disorders); (2) patient demographics; (3) patient comorbidities … cell disease, inflammatory pain, and headache disorders); (2) patient demographics (e.g., age, race … cell disease, inflammatory pain, headache disorders); (2) patient demographics; (3) patient comorbidities
  13. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2023.pdf
    January 01, 2023 - Dental Care for Persons With Sickle Cell Disease 8.
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
    September 30, 2015 - Appendix Table D-1. RCTs Table D-1. Randomized controlled trials Author, Year Study Design Duration Setting Country Eligibility Criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality Hruschak, 2021 RCT Duration:…
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveill-report-1.xlsx
    September 30, 2015 - Appendix Table D-1. RCTs Table D-1. Randomized controlled trials Author, Year Study Design Duration Setting Country Eligibility Criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality Hruschak, 2021 RCT Duration:…
  16. effectivehealthcare.ahrq.gov/sites/default/files/cer-229-opioid-treatments-chronic-pain-evidence-summary.pdf
    April 01, 2020 - pain (e.g., neuropathic, musculoskeletal [including low back pain], visceral pain, fibromyalgia, sicklecell disease, inflammatory pain, headache disorders, and degree of nociplasticity); (2) patient demographics … pain (e.g., neuropathic, musculoskeletal [including low back pain], visceral pain, fibromyalgia, sicklecell disease, inflammatory pain, headache disorders, and degree of nociplasticity); (2) patient demographics
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_disposition-comments.pdf
    April 25, 2013 - systemic sclerosis) that may be candidates for screening test studies, including patients with HIV, sicklecell anemia or trait, portal hypertension, family history of PAH or catecholaminergic drug use. … KQ1L For echocardiography, screening populations were SSc, liver transplant and Sickle cell disease. … I have some concerns about the inclusion of Sickle cell disease because of the multi-faceted causes
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/engaging-caregivers-appendix-b.xlsx
    May 29, 2025 - Table B-1. Evidence Table Table B-1. Details of included studies Author, Year Study Design Country Setting/Transition Adult, Adolescent, or Pediatric Patients Inclusion/Exclusion Criteria Condition Caregiver Details Patient Age, Years (Mean, Unless Specified) Caregiver Age, Years (Mean, Unless Specified) Patient Fe…
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/plant-based-treatments-revised-protocol.pdf
    March 29, 2023 - including low-back pain), visceral pain, fibromyalgia, inflammatory arthritis, headache disorders, sicklecell disease, and cancer pain (non-end of life) • Degree of nociplasticity/central sensitization
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/acute-pain-protocol-amended.pdf
    June 10, 2018 - Research Protocol (Amended): Treatment of Acute Pain--An Evidence Map Evidence-based Practice Center Technical Brief Protocol Project Title: Treatment of Acute Pain – An Evidence Map I. Background and Objectives for the Technical Brief Addressing the opioid epidemic in the United States is a key prior…

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: